Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 5/20 | 0.56 |
| ▸ | NPY1R | P25929 | 4/20 | 0.56 |
| ▸ | NPY2R | P49146 | 3/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.50 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.49 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.48 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29389091 | 0.92 | MMP2 (0.51) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL30512526 | 0.91 | BACE1 (0.51) | NPY4RNPY1RNPY2RENPEP | |
| SCHEMBL5032917 | 0.91 | ENPEP (0.56) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL29697056 | 0.90 | ENPEP (0.53) | NPY4RNPY1RNPY2RENPEP | |
| SCHEMBL30149609 | 0.90 | ENPEP (0.53) | NPY4RNPY1RNPY2RENPEP | |
| SCHEMBL29591071 | 0.90 | NPY4R (0.54) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31018320 | 0.90 | NPY4R (0.54) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL4420809 | 0.90 | ENPEP (0.56) | NPY4RNPY1RNPY2RERAP2LNPEP | |
| SCHEMBL30799753 | 0.89 | NPY4R (0.66) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29985813 | 0.89 | NPY4R (0.56) | NPY4RNPY1RNPY2RERAP2LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |